Kura Oncology and Kyowa Kirin submitted data from the KOMET-001 trial, which the agency will review and decide whether to approve the drug by Nov. 30.

Various factors contribute to disparities in 30-day readmission rates following allogeneic hematopoietic stem cell transplantation (allo-HCT) among patients with acute myeloid leukemia (AML), ...

DelveInsight’s Natural Killer (NK)-Cell Lymphoma Pipeline report depicts a robust space with 100+ active players working to develop 140+ pipeline therapies for Natural Killer (NK)-Cell Lymphoma ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New ...

Taurine, a common ingredient in energy drinks, has been linked to leukemia cell growth. New research suggests targeting taurine uptake for leukemia treatment strategies.

Therapeutic efforts in acute myeloid leukemia (AML ... developmental blocks and lineage-biased differentiation toward myeloid, lymphoid, and erythroid fates. Analysis showed that primitive ...

However, it has proven difficult to identify such specific antigens in certain cancer types, including acute myeloid leukemia ... with B cell leukemia/lymphoma and multiple myeloma (MM).

Venetoclax is under clinical development by AbbVie and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...

Solu Therapeutics is a biotechnology company dedicated to developing next-generation therapeutics to eliminate disease-driving cells in cancer, immunology and other therapeutic areas. The company's ...

What Is Acute Myeloid Leukemia? Acute myeloid leukemia (AML) is a type of blood cancer that starts in your bone marrow, which is the soft inner part of your bones where all your blood cells are made.

Acute myeloid leukemia (AML) pushes your bone marrow to make large numbers of abnormal and underdeveloped blood cells called blast cells. These cells crowd out healthy mature red blood cells ...